Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: Despite vaccination and early antibiotic treatment, pneumococcal meningitis remains a disease with significant mortality and morbidity. The resulting inflammatory response can lead to cochlear fibrosis, ossification where cochlear implant surgeries are far challenging. Our study aimed to investigate the preventive effect of controlled-release dexamethasone implant in such cases in terms of structural integrity.
Methods: Twenty-four rats were induced with pneumococcal meningitis and randomized into study (n = 16) and control (n = 8) groups. Controlled-release dexamethasone implants were placed transbullarly into the right round window of the study group. Bilateral cochleas underwent histological examination 3 months post-infection.
Results: In the study, cochlear effects of pneumococcal meningitis were evaluated. The basal turn was significantly more affected by fibrosis and ossification ( = .013 and .010, respectively). Compared with control ears, the dexamethasone implant group showed less fibrosis in all turns and less ossification in the basal turn ( = .014, .003, .044, and .035, respectively).
Conclusion: In pneumococcal meningitis, fibrosis and ossification occur more intensively in the basal turn of the cochlea. Controlled-release dexamethasone implants are effective in preventing cochlear ossification and fibrosis. The prevention from the structural damage indicates the potential role of these dexamethasone implants in post-meningitic hearing loss and easing cochlear implant surgeries.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12177190 | PMC |
| http://dx.doi.org/10.1177/00034894251322616 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mucoadhesive Andrographolide-Loaded Liposomes for Nasal Delivery Modulate Inflammatory Responses in Tumor Necrosis Factor Alpha-Induced Acute Lung Injury in Mice.
ACS Omega
August 2025
Division of Physiology, Chulabhorn International College of Medicine, Thammasat University, Pathumthani 12120, Thailand.
Inflammatory lung injury from a fever or sepsis can impair pulmonary function. While anti-inflammatory agents are commonly used, side effects could occur. Andrographolide (AGP) exhibits potent anti-inflammatory activity, making it a promising alternative treatment.
View Article and Find Full Text PDFPharmacokinetic Assessment of Drug Efflux from Erythrocytes Loaded with Corticosteroid Esters.
Pharm Res
August 2025
Department of Pharmaceutical Sciences, Division of Pharmacokinetics, Pharmacodynamics, and Systems Pharmacology, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, 404 Pharmacy Building, Buffalo, NY, 14214, USA.
Purpose: Drugs can be found in erythrocytes (RBC) in accordance with their physicochemical and specific binding properties, but particularly high concentrations can be attained using an ex vivo hypotonic pre-swelling method. Pharmacokinetic (PK) methodology and characterization of in vivo data for RBC-loaded corticosteroid prodrugs was sought.
Methods: Three studies providing in vitro and in vivo assessments of the pharmacokinetics of steroid ester prodrugs loaded into RBC were found.
Intelligently Actuating Dual-Barrier Hyaluronic Acid-Functionalized Inflammation-Responsive Nanohydrogel for Targeted Rheumatoid Arthritis Therapy.
ACS Appl Mater Interfaces
July 2025
Institute of Nano Science and Technology (INST), Sector 81, Mohali, Punjab 140306, India.
Rheumatoid arthritis (RA) is a chronic autoimmune condition marked by persistent synovial inflammation, cartilage degradation, and progressive joint dysfunction. Current intra-articular glucocorticoid therapies, though effective, are limited by rapid drug clearance, systemic side effects, and the need for repeated dosing. To overcome these limitations, we developed an inflammation-responsive, dual-barrier nanohydrogel system (Dex-LNP-HG) for sustained and targeted intra-articular delivery of dexamethasone (Dex).
View Article and Find Full Text PDFChondroitin sulfate polyelectrolyte nanoparticles for Controlled Release of Dexamethasone: Improvement of the Anticancer Activity of Curcumin.
Int J Biol Macromol
August 2025
Polymers and Pigments Department, National Research Centre, 33 El-Bohouth St., Dokki, P.O. 12622, Giza, Egypt. Electronic address:
Nanoparticle-based drug delivery systems have revolutionized oncology to overcome some critical burdens of conventional chemotherapy, such as non-specific toxicity, poor drug solubility, and rapid clearance. This study presents chondroitin sulfate (ChS)-based polyelectrolyte nanoparticles to achieve controlled release of dexamethasone (DEXA) while enhancing the anticancer efficacy of curcumin(Cur). The ChS polyelectrolyte nanoparticles (ChSNPs) were synthesized through electrostatic interactions between chitosan (Cs) and Chs polymers.
View Article and Find Full Text PDFResearch Trends and Developments in Nanomaterials for Rheumatoid Arthritis: A Comprehensive Bibliometric Analysis.
Drug Des Devel Ther
June 2025
Anhui University of Chinese Medicine, Hefei, 230012, People's Republic of China.
Background: Rheumatoid arthritis (RA) is one of the common diseases associated with job loss and disability. However, the existing diagnosis and treatment methods are limited by factors such as misdiagnosis, missed diagnosis, and toxic side effects. In recent years, remarkable progress has been made in applying nanomedicine for RA treatment.
View Article and Find Full Text PDF